share_log

HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $10

HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $10

HC Wainwright & Co.維持對伊頓醫藥的買入,將目標股價提高至10美元
Benzinga Real-time News ·  2022/09/26 06:32

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $9 to $10.

HC Wainwright & Co. 分析師Raghuram Selvaraju維持伊頓製藥公司(納斯達克股票代碼:ETON)的買入,並將目標股價從9美元上調至10美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論